Anil Korkut

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial

  Breast Cancer Research and Treatment · 2026-06-01

• RECOMBINE identifies recurrent composite markers of cell types and statesPreprint

  Genome Research · 2026-05-20

• Erratum: Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer

  JCO Precision Oncology · 2026-05-01

• Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors

  Cancer Discovery · 2026-03-26

• Design of combination therapeutics from protein response to drugs in ovarian cancer cells

  eLife · 2026-03-23

• CROCHET: a versatile pipeline for automated analysis and visual atlas creation from single-cell spatialomic data

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-17

• Abstract PD7-03: Circulating Immune Correlates of Pathological Response to Neoadjuvant Pembrolizumab plus Chemotherapy in High-Risk, Early-Stage Triple-Negative Breast Cancer

  Clinical Cancer Research · 2026-02-17

• A prognostic matrix gene expression signature defines functional glioblastoma phenotypes and niches

  Communications Biology · 2026-01-05 · 1 citations

• The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology

  Nature Reviews Clinical Oncology · 2026-01-05 · 3 citations

• 28. The actionable transcriptome: A framework for incorporating transcriptional profiling into precision oncology

  Cancer Genetics · 2025-12-01

• Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer

  npj Breast Cancer · 2025-11-20 · 3 citations

• Abstract C054: Clinical Utility of Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors

  Molecular Cancer Therapeutics · 2025-10-22

• Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer

  JCO Precision Oncology · 2025-10-01 · 2 citations

• Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profiles

  UNC Libraries · 2025-07-25

• Design of combination therapeutics from protein response to drugs in ovarian cancer cellsPreprint

  eLife · 2025-07-21

• Design of combination therapeutics from protein response to drugs in ovarian cancer cellsPreprint

  eLife · 2025-07-21

• Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profiles

  Scientific Reports · 2025-07-04 · 4 citations

• Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance

  Modern Pathology · 2025-06-18 · 6 citations

• Early on-treatment (on-Rx) tumor volume reduction (TVR) to predict response to the KEYNOTE-522 (KN-522) regimen in early stage triple negative breast cancer (TNBC).

  Journal of Clinical Oncology · 2025-05-28

• Design of combination therapeutics from protein response to drugs in ovarian cancer cellsPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-05-02